Literature DB >> 2483105

The carboxyl third of tau is tightly bound to paired helical filaments.

J Kondo1, T Honda, H Mori, Y Hamada, R Miura, M Ogawara, Y Ihara.   

Abstract

To obtain definitive evidence that tau is a component of paired helical filaments (PHF) in Alzheimer's disease, we fractionated and sequenced PHF-derived peptides according to a previously described procedure. In the PHF digest, we found four independent tau peptides that were located in the carboxyl third of tau. Subsequent extensive analysis of the PHF digest did not provide any other tau peptides. The conventional PHF antiserum and a new antiserum directed toward formic acid-denatured PHF reacted with the distinct CNBr fragments of tau localized on the carboxy-terminal portion of tau by protein sequencing. From these observations, we conclude that the carboxyl third of tau is tightly bound to PHF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2483105     DOI: 10.1016/0896-6273(88)90130-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  80 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Ultrastructure of the neuropil threads in the Alzheimer brain: their dendritic origin and accumulation in the senile plaques.

Authors:  H Yamaguchi; Y Nakazato; M Shoji; Y Ihara; S Hirai
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.

Authors:  M A Wrzolek; P A Merz; R Kascsak; I Grundke-Iqbal; K Iqbal; R Rubenstein; M Tonna-DeMasi; N L Goller; P Mehta; H M Wisniewski
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions.

Authors:  S Murayama; K Arima; Y Nakazato; J Satoh; M Oda; T Inose
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes.

Authors:  M Mercken; M Vandermeeren; U Lübke; J Six; J Boons; A Van de Voorde; J J Martin; J Gheuens
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

8.  Presence of two different fibril subtypes in the Pick body: an immunoelectron microscopic study.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

9.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

10.  Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease.

Authors:  R Mena; P Edwards; O Pérez-Olvera; C M Wischik
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.